MiMedx Group MDXG Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.7M-23.2% | $48.58M+15.7% | $40.83M-58.0% | $31.96M-67.4% | $39.96M-51.0% | ||
| $10.44M-38.1% | $16.4M-3.2% | $18.63M+12.0% | $17.52M+1.8% | $16.86M-1.9% | ||
| -$3.56M+67.8% | -$8.71M+30.2% | -$8.99M-132% | -$6.04M-120% | -$11.06M-131% | ||
| $7.24M+536% | $6.52M+997% | $3.6M+323% | $1.27M-19.6% | $1.14M-33.4% | ||
| -$9.02M-241% | $26.39M+934% | $27.76M+372% | $17.7M+227% | $6.41M-54.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.77M— | $8.82M— | —— | —— | —— | ||
| $380K— | $289K— | —— | —— | —— | ||
| $593K— | $641K— | $654K— | $899K— | —— | ||
| $1.29M-1.2% | $1.26M-3.7% | $1.28M-0.5% | $1.29M+3.0% | $1.3M+3.9% | ||
| $70.58M+7.7% | $74M+11.8% | $67.83M+17.6% | $58.12M+14.3% | $65.52M+78.0% | ||
| $1.23M+33.8% | $1.03M-38.6% | $1.01M-45.3% | $990K-57.0% | $916K-63.3% | ||
| $8.76M+206% | $3.76M-52.1% | $6.26M+16.7% | $3.2M-40.4% | $2.86M-42.8% | ||
| -$12.12M-197% | -$6.89M+29.0% | -$9.32M-25.7% | -$4.06M+49.6% | -$4.08M+45.6% | ||
| $2.56M-13.1% | $3.12M+18.1% | $3.1M+18.6% | $3.12M+24.9% | $2.95M+36.9% | ||
| -$5.12M-40.7% | -$5.41M+84.2% | -$5.23M+87.8% | -$4.37M+89.7% | -$3.64M+91.3% | ||
| $53.34M-7.9% | $61.71M+175% | $53.28M+598% | $49.83M+12,843% | $57.94M+555% | ||
| -$3.56M+67.8% | -$8.71M+30.2% | -$8.99M-132% | -$6.04M-120% | -$11.06M-131% | ||
| -$2.65M-181% | $8.99M+210% | $9.07M+1,611% | $6.81M+339% | $3.26M+23,407% | ||
| $5.77M— | $8.82M— | —— | —— | —— | ||
| $1.29M-1.2% | $1.26M-3.7% | $1.28M-0.5% | $1.29M+3.0% | $1.3M+3.9% | ||
| $7.24M+536% | $6.52M+997% | $3.6M+323% | $1.27M-19.6% | $1.14M-33.4% | ||
| —— | $2.09M+5,397% | $1.58M+2,136% | $1.06M+933% | $550.75K+306% | ||
| $8.76M+206% | $3.76M-52.1% | $6.26M+16.7% | $3.2M-40.4% | $2.86M-42.8% | ||
| $1.23M+33.8% | $1.03M-38.6% | $1.01M-45.3% | $990K-57.0% | $916K-63.3% | ||
| —— | $0+100% | -$14.25K+74.4% | -$28.5K+47.7% | -$42.75K+19.7% | ||
| —— | —— | —— | —— | —— | ||
| $1.43M+473% | $1.29M+1,518% | $1.09M— | $568K— | $250K— | ||
| —— | —— | —— | —— | —— | ||
| $875K-12.5% | $1M0.0% | $1M+233% | $1M+300% | $1M+500% | ||
| $69.36M+7.4% | $72.97M+13.1% | $66.82M+19.7% | $57.13M+17.7% | $64.6M+88.3% | ||
| $69.36M+7.4% | $72.97M+13.1% | $66.82M+19.7% | $57.13M+17.7% | $64.6M+88.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MiMedx Group generate?
- MiMedx Group (MDXG) generated $70.6M in operating cash flow over the trailing twelve months.
- What is MiMedx Group's free cash flow?
- After $1.2M of capital expenditures, MiMedx Group's free cash flow was $69.4M over the trailing twelve months, up 7.4% year over year.
- Where does MiMedx Group's cash flow data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
